侵袭性与尿抗原确诊肺炎链球菌社区获得性肺炎比较
该前瞻性观察研究纳入2000至2014年连续非免疫抑制社区获得性肺炎患者,比较侵袭性肺炎链球菌肺炎(IPP)与尿抗原阳性但培养阴性的非侵袭性肺炎链球菌肺炎(NIPP)。在779例确诊患者中,NIPP占54%,IPP患者病情更重、炎症指标更高、氧合更差、并发症更多、住院更长,但IPP并非30天死亡的独立危险因素。
要点
- 尿抗原试验可确诊大量培养阴性的肺炎链球菌肺炎,NIPP占确诊者的54%。
- IPP患者入院时病情更重、炎症指标更高、氧合更差,并发症和住院时间更多。
- IPP并非30天死亡的独立危险因素,NIPP对肺炎链球菌肺炎负担评估很重要。
核心结论
- 高比例确诊肺炎链球菌肺炎通过尿抗原试验诊断。
- IPP与NIPP临床特征和结局存在差异,但IPP并非30天死亡的独立危险因素。
- NIPP对肺炎链球菌肺炎的负担评估具有重要意义。
研究设计与样本
- 共分析779例(占5132例的15%),其中IPP 361例(46%),NIPP 418例(54%)。
- IPP定义为血培养或胸水培养阳性,NIPP定义为尿抗原阳性且血或胸水培养阴性。
主要发现
- 与IPP相比,NIPP患者慢性肺病更多、既往抗生素使用更频繁。
- IPP患者入院时社区获得性肺炎更严重、炎症标志物更高、氧合更差。
- IPP患者肺部并发症更多、肺外并发症更多、临床稳定时间更长、住院时间更长。
- 年龄、慢性肝病、机械通气、急性肾衰竭是30天粗死亡率的独立危险因素。
- IPP或NIPP均不是30天死亡率的独立危险因素。
临床怎么用
- 尿抗原试验有助于识别培养阴性的肺炎链球菌肺炎,不应仅依赖培养诊断。
- IPP患者入院时病情更重,应关注并发症和住院时间管理。
- 评估肺炎链球菌肺炎负担时需同时考虑NIPP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The burden of pneumococcal disease is measured only through patients with invasive pneumococcal disease. The urinary antigen test (UAT) for pneumococcus has exhibited high sensitivity and specificity. We aimed to compare the pneumococcal pneumonias diagnosed as invasive disease with pneumococcal pneumonias defined by UAT results. METHODS: A prospective observational study of consecutive nonimmunosuppressed patients with community-acquired pneumonia was performed from January 2000 to December 2014. Patients were stratified into two groups: invasive pneumococcal pneumonia (IPP) defined as a positive blood culture or pleural fluid culture result and noninvasive pneumococcal pneumonia (NIPP) defined as a positive UAT result with negative blood or pleural fluid culture result. RESULTS: We analyzed 779 patients (15%) of 5,132, where 361 (46%) had IPP and 418 (54%) had NIPP. Compared with the patients with IPP, those with NIPP presented more frequent chronic pulmonary disease and received previous antibiotics more frequently. Patients with IPP presented more severe community-acquired pneumonia, higher levels of inflammatory markers, and worse oxygenation at admission; more pulmonary complications; greater extrapulmonary complications; longer time to clinical stability; and longer length of hospital stay compared with the NIPP group. Age, chronic liver disease, mechanical ventilation, and acute renal failure were independent risk factors for 30-day crude mortality. Neither IPP nor NIPP was an independent risk factor for 30-day mortality. CONCLUSIONS: A high percentage of confirmed pneumococcal pneumonia is diagnosed by UAT. Despite differences in clinical characteristics and outcomes, IPP is not an independent risk factor for 30-day mortality compared with NIPP, reinforcing the importance of NIPP for pneumococcal pneumonia.
引用
- Ceccato A, Torres A, Cilloniz C, et al. Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia. Chest. 2017. PMID: 28093269. doi:10.1016/j.chest.2017.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。